Strategic Foresight in Oral Solid Dose Development

This technical report examines the strategic foresight necessary for mastering oral solid dose (OSD) development, focusing on four key pillars: technology and expertise, global networks, customized services, and regulatory excellence. These pillars are essential for navigating the complexities of oral drug development, addressing challenges early, and delivering innovative therapies efficiently. The report outlines how integrating in silico modeling tools and leveraging global CDMO capabilities can streamline processes, mitigate risks, and meet evolving market demands. It emphasizes the importance of predictive tools in driving early problem-solving and process optimization. The report also highlights the necessity of a robust global network for scalability and compliance, customized services for unique project needs, and proactive quality and regulatory strategies to reduce risks. By focusing on these areas, development teams can enhance their ability to make informed decisions, optimize formulations, and ensure successful market entry, ultimately improving the chances of delivering life-changing treatments to patients.